Cell phenotype | Median MFI (range)/percentage positive (%) index | Changea | P | n | |
---|---|---|---|---|---|
 | Day 0 | Day 8 |  |  |  |
CD25 | 8.0 (2–49)/9% | 61 (6–884)/18% | 7.5 | <0.0001 | 40 |
CD69 | 5.0 (2–43)/1.1% | 41 (5–552)/26.7% | 8 | <0.0001 | 41 |
HLA-DR | 19 (4–130)/9% | 60 (11–238)/15% | 3 | 0.0052 | 15 |
CD62L | 22 (8–255)/17% | 339 (7–1,040)/58% | 15 | <0.0001 | 31 |
CD18 | 107 (9–1,026)/97.5% | 319 (53–2,040)/98.5% | 3 | 0.0085 | 21 |
CD29 | 85 (6–668)/81% | 152 (14–582)/97% | 2 | 0.0132 | 35 |
CD49d | 180 (5–634)/73.3% | 465 (13–1,461)/82.3% | 2.6 | <0.0001 | 42 |
CCR7 | 12 (4–57)/7.4% | 13 (3–138)/8.6% | 1 | NS | 42 |
CXCR4 | 52 (18–494)/29% | 270 (124–896)/86.4% | 5 | <0.0001 | 21 |
CXCR3 | 32.3 (9–309)/34.3% | 40.4 (17–129)/34.0% | 1 | NS | 21 |
CCR5 | 8.3 (4–28)/2% | 10.7 (4–262)/6% | 1 | NS | 21 |